L-selectin in trauma patients: a marker for organ dysfunction and outcome?

Background Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are important factors affecting morbidity and mortality after trauma. Adhesion molecules, e.g. L‐selectin (CD62 L), play crucial roles in both conditions. Patients and methods In 51 multiple trau...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical investigation 1999-12, Vol.29 (12), p.1077-1086
Hauptverfasser: Kerner, T, Ahlers, O, Spielmann, S, Keh, D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1086
container_issue 12
container_start_page 1077
container_title European journal of clinical investigation
container_volume 29
creator Kerner, T
Ahlers, O
Spielmann, S
Keh, D
description Background Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are important factors affecting morbidity and mortality after trauma. Adhesion molecules, e.g. L‐selectin (CD62 L), play crucial roles in both conditions. Patients and methods In 51 multiple trauma patients, CD62 L surface expression on granulocytes, monocytes, lymphocytes, as well as sCD62 L plasma concentrations were determined during the first 6 days after trauma, starting at the site of accident. Clinical parameters were severity of injury scores (ISS, APACHE II), requirement of red blood cell transfusion, acute lung or liver failure, development of MODS or SIRS, early (≤ 6 d) or late (> 6 d), and outcome. Results CD62 L expression was reversibly elevated on granulocytes, T cells and monocytes in comparison with initial values. sCD62 L plasma concentrations did not show temporal variations but were depressed throughout observation period, in comparison with healthy controls. Lung failure within the first 6 days was associated with increased CD62 L expression on monocytes and B cells on admission and increased sCD62 L concentrations after 12 and 24 h. Patients with more severe injuries (APACHE II > 20 points) had higher sCD62 L concentrations after 24 h. Non‐survivors had decreased sCD62 L (on admission) and T‐cell CD62 L expression (after 4 h). Patients with early MODS or SIRS showed increased monocyte CD62 L expression after 6 days. Conclusions In multiple trauma patients, severe organ dysfunction is associated with altered CD62 L expression on leukocytes and circulating sCD62 L plasma concentrations. However, the obvious complexity of the pattern currently restricts use of CD62 L quantitation for clinical purposes.
doi_str_mv 10.1046/j.1365-2362.1999.00567.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69329323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>47370778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4587-abb9d2d80488512c27045313adf0aba4c10ef2b15659e2c42975054aa00c55ba3</originalsourceid><addsrcrecordid>eNqNkV2L1DAUhoMo7rj6FySIeNd68tUmIogM6-7KsIIou3fhNE2lYz_GpMWZf2_GDqt4JQQSOM9zcvKGEMogZyCL19uciUJlXBQ8Z8aYHEAVZb5_QFb3hYdkBcBkxk3Jz8iTGLcAoJngj8kZA6WFVOWKfNxk0XfeTe1A05oCzj3SHU6tH6b4hiLtMXz3gTZjoGP4hgOtD7GZh2SMA8WhpuM8ubH3756SRw120T877efk64eLL-urbPPp8nr9fpM5qXSZYVWZmtcapNaKccdLkEowgXUDWKF0DHzDK6YKZTx3Ms2vQElEAKdUheKcvFr67sL4Y_Zxsn0bne86HPw4R1sYwdMSCXzxD7gd5zCk2WwKDUoAKROkF8iFMcbgG7sLbXrzwTKwx7Dt1h4ztcdMj56xv8O2-6Q-P_Wfq97Xf4lLugl4eQIwOuyagINr4x-OgxbaJOztgv1sO3_47_vtxfo6HZKeLXobJ7-_19O32VQtlb29ubRXd-bz7c2dTL1-ARbfp4M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199070044</pqid></control><display><type>article</type><title>L-selectin in trauma patients: a marker for organ dysfunction and outcome?</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Kerner, T ; Ahlers, O ; Spielmann, S ; Keh, D</creator><creatorcontrib>Kerner, T ; Ahlers, O ; Spielmann, S ; Keh, D</creatorcontrib><description>Background Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are important factors affecting morbidity and mortality after trauma. Adhesion molecules, e.g. L‐selectin (CD62 L), play crucial roles in both conditions. Patients and methods In 51 multiple trauma patients, CD62 L surface expression on granulocytes, monocytes, lymphocytes, as well as sCD62 L plasma concentrations were determined during the first 6 days after trauma, starting at the site of accident. Clinical parameters were severity of injury scores (ISS, APACHE II), requirement of red blood cell transfusion, acute lung or liver failure, development of MODS or SIRS, early (≤ 6 d) or late (&gt; 6 d), and outcome. Results CD62 L expression was reversibly elevated on granulocytes, T cells and monocytes in comparison with initial values. sCD62 L plasma concentrations did not show temporal variations but were depressed throughout observation period, in comparison with healthy controls. Lung failure within the first 6 days was associated with increased CD62 L expression on monocytes and B cells on admission and increased sCD62 L concentrations after 12 and 24 h. Patients with more severe injuries (APACHE II &gt; 20 points) had higher sCD62 L concentrations after 24 h. Non‐survivors had decreased sCD62 L (on admission) and T‐cell CD62 L expression (after 4 h). Patients with early MODS or SIRS showed increased monocyte CD62 L expression after 6 days. Conclusions In multiple trauma patients, severe organ dysfunction is associated with altered CD62 L expression on leukocytes and circulating sCD62 L plasma concentrations. However, the obvious complexity of the pattern currently restricts use of CD62 L quantitation for clinical purposes.</description><identifier>ISSN: 0014-2972</identifier><identifier>EISSN: 1365-2362</identifier><identifier>DOI: 10.1046/j.1365-2362.1999.00567.x</identifier><identifier>PMID: 10583457</identifier><language>eng</language><publisher>Oxford BSL: Blackwell Science Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biomarkers ; Demography ; Female ; Humans ; Immunoassay ; L-selectin ; L-Selectin - blood ; L-Selectin - metabolism ; Leukocytes - metabolism ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Multiple Organ Failure - blood ; Multiple Organ Failure - etiology ; Multiple Organ Failure - metabolism ; Multiple Organ Failure - mortality ; organ dysfunction ; Outcome Assessment (Health Care) ; Predictive Value of Tests ; Prospective Studies ; trauma ; Traumas. Diseases due to physical agents ; Wounds and Injuries - blood ; Wounds and Injuries - complications ; Wounds and Injuries - diagnosis ; Wounds and Injuries - metabolism ; Wounds and Injuries - mortality</subject><ispartof>European journal of clinical investigation, 1999-12, Vol.29 (12), p.1077-1086</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. Dec 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4587-abb9d2d80488512c27045313adf0aba4c10ef2b15659e2c42975054aa00c55ba3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2362.1999.00567.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2362.1999.00567.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1208389$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10583457$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kerner, T</creatorcontrib><creatorcontrib>Ahlers, O</creatorcontrib><creatorcontrib>Spielmann, S</creatorcontrib><creatorcontrib>Keh, D</creatorcontrib><title>L-selectin in trauma patients: a marker for organ dysfunction and outcome?</title><title>European journal of clinical investigation</title><addtitle>European Journal of Clinical Investigation</addtitle><description>Background Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are important factors affecting morbidity and mortality after trauma. Adhesion molecules, e.g. L‐selectin (CD62 L), play crucial roles in both conditions. Patients and methods In 51 multiple trauma patients, CD62 L surface expression on granulocytes, monocytes, lymphocytes, as well as sCD62 L plasma concentrations were determined during the first 6 days after trauma, starting at the site of accident. Clinical parameters were severity of injury scores (ISS, APACHE II), requirement of red blood cell transfusion, acute lung or liver failure, development of MODS or SIRS, early (≤ 6 d) or late (&gt; 6 d), and outcome. Results CD62 L expression was reversibly elevated on granulocytes, T cells and monocytes in comparison with initial values. sCD62 L plasma concentrations did not show temporal variations but were depressed throughout observation period, in comparison with healthy controls. Lung failure within the first 6 days was associated with increased CD62 L expression on monocytes and B cells on admission and increased sCD62 L concentrations after 12 and 24 h. Patients with more severe injuries (APACHE II &gt; 20 points) had higher sCD62 L concentrations after 24 h. Non‐survivors had decreased sCD62 L (on admission) and T‐cell CD62 L expression (after 4 h). Patients with early MODS or SIRS showed increased monocyte CD62 L expression after 6 days. Conclusions In multiple trauma patients, severe organ dysfunction is associated with altered CD62 L expression on leukocytes and circulating sCD62 L plasma concentrations. However, the obvious complexity of the pattern currently restricts use of CD62 L quantitation for clinical purposes.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Demography</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>L-selectin</subject><subject>L-Selectin - blood</subject><subject>L-Selectin - metabolism</subject><subject>Leukocytes - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Multiple Organ Failure - blood</subject><subject>Multiple Organ Failure - etiology</subject><subject>Multiple Organ Failure - metabolism</subject><subject>Multiple Organ Failure - mortality</subject><subject>organ dysfunction</subject><subject>Outcome Assessment (Health Care)</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>trauma</subject><subject>Traumas. Diseases due to physical agents</subject><subject>Wounds and Injuries - blood</subject><subject>Wounds and Injuries - complications</subject><subject>Wounds and Injuries - diagnosis</subject><subject>Wounds and Injuries - metabolism</subject><subject>Wounds and Injuries - mortality</subject><issn>0014-2972</issn><issn>1365-2362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkV2L1DAUhoMo7rj6FySIeNd68tUmIogM6-7KsIIou3fhNE2lYz_GpMWZf2_GDqt4JQQSOM9zcvKGEMogZyCL19uciUJlXBQ8Z8aYHEAVZb5_QFb3hYdkBcBkxk3Jz8iTGLcAoJngj8kZA6WFVOWKfNxk0XfeTe1A05oCzj3SHU6tH6b4hiLtMXz3gTZjoGP4hgOtD7GZh2SMA8WhpuM8ubH3756SRw120T877efk64eLL-urbPPp8nr9fpM5qXSZYVWZmtcapNaKccdLkEowgXUDWKF0DHzDK6YKZTx3Ms2vQElEAKdUheKcvFr67sL4Y_Zxsn0bne86HPw4R1sYwdMSCXzxD7gd5zCk2WwKDUoAKROkF8iFMcbgG7sLbXrzwTKwx7Dt1h4ztcdMj56xv8O2-6Q-P_Wfq97Xf4lLugl4eQIwOuyagINr4x-OgxbaJOztgv1sO3_47_vtxfo6HZKeLXobJ7-_19O32VQtlb29ubRXd-bz7c2dTL1-ARbfp4M</recordid><startdate>199912</startdate><enddate>199912</enddate><creator>Kerner, T</creator><creator>Ahlers, O</creator><creator>Spielmann, S</creator><creator>Keh, D</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>199912</creationdate><title>L-selectin in trauma patients: a marker for organ dysfunction and outcome?</title><author>Kerner, T ; Ahlers, O ; Spielmann, S ; Keh, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4587-abb9d2d80488512c27045313adf0aba4c10ef2b15659e2c42975054aa00c55ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Demography</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>L-selectin</topic><topic>L-Selectin - blood</topic><topic>L-Selectin - metabolism</topic><topic>Leukocytes - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Multiple Organ Failure - blood</topic><topic>Multiple Organ Failure - etiology</topic><topic>Multiple Organ Failure - metabolism</topic><topic>Multiple Organ Failure - mortality</topic><topic>organ dysfunction</topic><topic>Outcome Assessment (Health Care)</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>trauma</topic><topic>Traumas. Diseases due to physical agents</topic><topic>Wounds and Injuries - blood</topic><topic>Wounds and Injuries - complications</topic><topic>Wounds and Injuries - diagnosis</topic><topic>Wounds and Injuries - metabolism</topic><topic>Wounds and Injuries - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kerner, T</creatorcontrib><creatorcontrib>Ahlers, O</creatorcontrib><creatorcontrib>Spielmann, S</creatorcontrib><creatorcontrib>Keh, D</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kerner, T</au><au>Ahlers, O</au><au>Spielmann, S</au><au>Keh, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>L-selectin in trauma patients: a marker for organ dysfunction and outcome?</atitle><jtitle>European journal of clinical investigation</jtitle><addtitle>European Journal of Clinical Investigation</addtitle><date>1999-12</date><risdate>1999</risdate><volume>29</volume><issue>12</issue><spage>1077</spage><epage>1086</epage><pages>1077-1086</pages><issn>0014-2972</issn><eissn>1365-2362</eissn><abstract>Background Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are important factors affecting morbidity and mortality after trauma. Adhesion molecules, e.g. L‐selectin (CD62 L), play crucial roles in both conditions. Patients and methods In 51 multiple trauma patients, CD62 L surface expression on granulocytes, monocytes, lymphocytes, as well as sCD62 L plasma concentrations were determined during the first 6 days after trauma, starting at the site of accident. Clinical parameters were severity of injury scores (ISS, APACHE II), requirement of red blood cell transfusion, acute lung or liver failure, development of MODS or SIRS, early (≤ 6 d) or late (&gt; 6 d), and outcome. Results CD62 L expression was reversibly elevated on granulocytes, T cells and monocytes in comparison with initial values. sCD62 L plasma concentrations did not show temporal variations but were depressed throughout observation period, in comparison with healthy controls. Lung failure within the first 6 days was associated with increased CD62 L expression on monocytes and B cells on admission and increased sCD62 L concentrations after 12 and 24 h. Patients with more severe injuries (APACHE II &gt; 20 points) had higher sCD62 L concentrations after 24 h. Non‐survivors had decreased sCD62 L (on admission) and T‐cell CD62 L expression (after 4 h). Patients with early MODS or SIRS showed increased monocyte CD62 L expression after 6 days. Conclusions In multiple trauma patients, severe organ dysfunction is associated with altered CD62 L expression on leukocytes and circulating sCD62 L plasma concentrations. However, the obvious complexity of the pattern currently restricts use of CD62 L quantitation for clinical purposes.</abstract><cop>Oxford BSL</cop><pub>Blackwell Science Ltd</pub><pmid>10583457</pmid><doi>10.1046/j.1365-2362.1999.00567.x</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2972
ispartof European journal of clinical investigation, 1999-12, Vol.29 (12), p.1077-1086
issn 0014-2972
1365-2362
language eng
recordid cdi_proquest_miscellaneous_69329323
source MEDLINE; Wiley Online Library All Journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Biomarkers
Demography
Female
Humans
Immunoassay
L-selectin
L-Selectin - blood
L-Selectin - metabolism
Leukocytes - metabolism
Male
Medical sciences
Middle Aged
Miscellaneous
Multiple Organ Failure - blood
Multiple Organ Failure - etiology
Multiple Organ Failure - metabolism
Multiple Organ Failure - mortality
organ dysfunction
Outcome Assessment (Health Care)
Predictive Value of Tests
Prospective Studies
trauma
Traumas. Diseases due to physical agents
Wounds and Injuries - blood
Wounds and Injuries - complications
Wounds and Injuries - diagnosis
Wounds and Injuries - metabolism
Wounds and Injuries - mortality
title L-selectin in trauma patients: a marker for organ dysfunction and outcome?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T18%3A53%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=L-selectin%20in%20trauma%20patients:%20a%20marker%20for%20organ%20dysfunction%20and%20outcome?&rft.jtitle=European%20journal%20of%20clinical%20investigation&rft.au=Kerner,%20T&rft.date=1999-12&rft.volume=29&rft.issue=12&rft.spage=1077&rft.epage=1086&rft.pages=1077-1086&rft.issn=0014-2972&rft.eissn=1365-2362&rft_id=info:doi/10.1046/j.1365-2362.1999.00567.x&rft_dat=%3Cproquest_cross%3E47370778%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199070044&rft_id=info:pmid/10583457&rfr_iscdi=true